OmniVira

SARS-CoV-2-Specific Antibodies in Domestic Cats during First COVID-19 Wave, Europe.

Claudia Schulz Byron Martina Monica Mirolo Elisabeth Müller Ruth Klein Holger Volk Herman Egberink Mariana Gonzalez-Hernandez Franziska Kaiser Maren von Köckritz-Blickwede Albert Osterhaus
PMID34695368 DOI10.3201/eid2712.211252 Year2021 Journal Emerging infectious diseases Emerg Infect Dis Languageeng Statusppublish

Abstract

We conducted a severe acute respiratory syndrome coronavirus 2 antibody seroprevalence study among >2,000 domestic cats from 4 countries during the first coronavirus disease wave in Europe. We found 4.4% seroprevalence using a virus neutralization test and 4.3% using a receptor-binding domain ELISA, demonstrating probable human-to-cat transmission.

Supporting text Virus Host Location
cat 22 coronavirus 195 coronavirus disease 15 COVID-19 467 ELISA 28 Europe 28 felines 5 neutralization tests 32 One Health 98 respiratory infections 30 SARS 6 SARS-CoV-2 550 serology 50 severe acute respiratory syndrome coronavirus 2 20 viruses 117 zoonoses 477 COVID-19 425 SARS-CoV-2 453 Animals 1948 Antibodies, Viral 212 Cats 120 Europe 27 Humans 1440 Seroepidemiologic Studies 113

Evidence records

2 total
Zoonotic Surveillance
2 records · 1 evidence types
Evidence type Serological Evidence
2 records
OVE5268 Serological Evidence
Key finding

SARS-CoV-2–specific antibodies were detected in domestic cats from four European countries, with 4.4% seroprevalence by neutralization and 4.3% by ELISA.

Virus
Severe acute respiratory syndrome coronavirus 2
Host
domestic cat Felis catus Natural host
Location
Not specified
Supporting text

We conducted a severe acute respiratory syndrome coronavirus 2 antibody seroprevalence study among >2,000 domestic cats from 4 countries during the first coronavirus disease wave in Europe.

Method
virus neutralization test | receptor-binding domain ELISA
Sample type
serum
OVE5269 Serological Evidence
Key finding

Probable human-to-cat transmission of SARS-CoV-2 was demonstrated by detection of SARS-CoV-2-specific antibodies in domestic cats during the first COVID-19 wave in Europe.

Virus
Severe acute respiratory syndrome coronavirus 2
Host
human Homo sapiens Natural host domestic cat Felis catus Natural host
Location
Europe
Supporting text

We conducted a severe acute respiratory syndrome coronavirus 2 antibody seroprevalence study among >2,000 domestic cats from 4 countries during the first coronavirus disease wave in Europe. We found 4.4% seroprevalence using a virus neutralization test and 4.3% using a receptor-binding domain ELISA, demonstrating probable human-to-cat transmission.

Method
virus neutralization test | receptor-binding domain ELISA